메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 33, Issue 26, 2015, Pages 2928-
Optimal concurrent chemoradiotherapy regimen in non-small-cell lung cancer: Prospective, randomized data still required
Author keywords

[No Author keywords available]
Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; PACLITAXEL;
EID: 84942436960     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.61.7332     Document Type: Letter
Times cited : (3)
References (10)
  • 1
    • 84923196894 scopus 로고    scopus 로고
    • Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: An analysis of Veteran Health Administration data
    • Santana-Davila S, Devisetty K, Szabo A, et al: Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: An analysis of Veteran Health Administration data. J Clin Oncol 33:567-574, 2015
    • (2015) J Clin Oncol , vol.33 , pp. 567-574
    • Santana-Davila, S.1    Devisetty, K.2    Szabo, A.3
  • 2
    • 80054072961 scopus 로고    scopus 로고
    • Sequential vs concurrent chemoradiotherapy for stage III non-small cell lung cancer: Randomized phase III trial RTOG 9410
    • Curran WJ Jr, Paulus R, Langer CJ, et al: Sequential vs concurrent chemoradiotherapy for stage III non-small cell lung cancer: Randomized phase III trial RTOG 9410. J Natl Cancer Inst 103:1452-1460, 2011
    • (2011) J Natl Cancer Inst , vol.103 , pp. 1452-1460
    • Curran, W.J.1    Paulus, R.2    Langer, C.J.3
  • 3
    • 0026580034 scopus 로고
    • Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer
    • Schaake-Koning C, Van den Bogaert W, Daleslo O, et al: Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326:524-530, 1992
    • (1992) N Engl J Med , vol.326 , pp. 524-530
    • Schaake-Koning, C.1    Van Den Bogaert, W.2    Daleslo, O.3
  • 4
    • 77952298828 scopus 로고    scopus 로고
    • Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer
    • Auperin A, Le Pechoux C, Roland E, et al: Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 28:2181-2190, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 2181-2190
    • Auperin, A.1    Le Pechoux, C.2    Roland, E.3
  • 5
    • 34248651350 scopus 로고    scopus 로고
    • Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: Cancer Leukemia Group B
    • Vokes EE, Herndon JE 2nd, Kelly NJ, et al: Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: Cancer Leukemia Group B. J Clin Oncol 25:1698-1704, 2007
    • (2007) J Clin Oncol , vol.25 , pp. 1698-1704
    • Vokes, E.E.1    Herndon, J.E.2    Kelly, N.J.3
  • 6
    • 84862802175 scopus 로고    scopus 로고
    • Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III NSCLC
    • Wang L, Wu S, OU G, et al: Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III NSCLC. Lung Cancer 77:89-96, 2012
    • (2012) Lung Cancer , vol.77 , pp. 89-96
    • Wang, L.1    Wu, S.2    Ou, G.3
  • 7
    • 24944542868 scopus 로고    scopus 로고
    • Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: A randomized phase II locally advanced multi-modality protocol
    • Belani CP, Choy H, Bonomi P, et al: Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: A randomized phase II locally advanced multi-modality protocol. J Clin Oncol 23:5883-5891, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 5883-5891
    • Belani, C.P.1    Choy, H.2    Bonomi, P.3
  • 8
    • 1342268525 scopus 로고    scopus 로고
    • American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guidelines: Update 2003
    • Pfister DG, Johnson DH, Azzoli CG, et al: American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guidelines: Update 2003. J Clin Oncol 22:330-353, 2004
    • (2004) J Clin Oncol , vol.22 , pp. 330-353
    • Pfister, D.G.1    Johnson, D.H.2    Azzoli, C.G.3
  • 9
    • 0021868905 scopus 로고
    • The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer
    • Feinstein AR, Sosin DM, Wells CK: The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604-1608, 1985
    • (1985) N Engl J Med , vol.312 , pp. 1604-1608
    • Feinstein, A.R.1    Sosin, D.M.2    Wells, C.K.3
  • 10
    • 34548457234 scopus 로고    scopus 로고
    • Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours
    • Goldstraw P, Crowley J, Chansky K, et al: The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2:706-714, 2007
    • (2007) J Thorac Oncol , vol.2 , pp. 706-714
    • Goldstraw, P.1    Crowley, J.2    Chansky, K.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.